Aramark

NYSE:ARMK Stock Report

Market Cap: US$11.9b

Aramark Future Growth

Future criteria checks 2/6

Aramark is forecast to grow earnings and revenue by 17.8% and 5.9% per annum respectively. EPS is expected to grow by 17.8% per annum. Return on equity is forecast to be 17.1% in 3 years.

Key information

17.8%

Earnings growth rate

17.79%

EPS growth rate

Hospitality earnings growth18.0%
Revenue growth rate5.9%
Future return on equity17.13%
Analyst coverage

Good

Last updated27 Apr 2026

Recent future growth updates

Earnings Miss: Aramark Missed EPS By 19% And Analysts Are Revising Their Forecasts

Nov 20
Earnings Miss: Aramark Missed EPS By 19% And Analysts Are Revising Their Forecasts

Recent updates

ARMK: Organic Wins And 2026 Health Contract Will Support Future Free Cash Flow

The analyst price target for Aramark is adjusted modestly higher to $47.63 from $47.16, with analysts pointing to steadier revenue growth assumptions, a slightly higher profit margin outlook, and recent positive research highlighting organic growth and new contract wins as support for the change. Analyst Commentary Recent research around Aramark centers on organic growth trends, contract wins and how these factors feed into valuation.

ARMK: Organic Wins And 2026 Health Contract Will Support Future Free Cash Flow

Aramark's analyst price target has inched higher, with a modest fair value adjustment to about $47.16 as analysts highlight stronger than expected organic growth trends, a new RWJ Barnabas Health contract scheduled to ramp up in 2026, and generally constructive sector views as key supports. Analyst Commentary Bullish analysts are generally constructive on Aramark, pointing to recent price target increases and renewed coverage with higher fair value estimates.

ARMK: New Contracts And Buybacks Will Support Future Free Cash Flow

Analysts have raised the implied fair value for Aramark by about $0.47 to $47.09, reflecting updated assumptions around revenue growth, profitability and future P/E in the context of a recent wave of higher $50 price targets across research reports. Analyst Commentary Recent research updates cluster around a US$50 price target, with several firms lifting their views in quick succession.

Aramark's Growth Story Isn't Over Yet

Mar 24

ARMK: Contract Wins And Buybacks Will Support Higher FY26 Cash Generation

Narrative Update Analysts have lifted their average price target on Aramark by about $3 to $50, citing stronger than expected organic growth and increased visibility from a new RWJ Barnabas Health contract, as well as broader optimism regarding revenue, EPS and free cash flow trends into 2026. Analyst Commentary Recent Street research on Aramark centers on higher price targets and fresh coverage, with most of the discussion tied to organic growth trends, contract wins and expectations for earnings and cash flow through 2026.

ARMK: Contract Wins And Buybacks Will Support Stronger FY26 Earnings Delivery

Analysts have lifted their average Aramark price target from about $44.60 to roughly $46.63. The updated views factor in recent organic growth trends and expectations for future contract contributions and earnings power.

ARMK: Contract Timing Delays Will Support Stronger FY26 Earnings Delivery

Narrative Update on Aramark Analysts have trimmed their Aramark price target to US$44 from US$49, citing a shift in expected revenue timing as client driven delays in new contract starts across Corrections, Workplace Experience, and Healthcare push more of the projected contribution into FY26. They continue to model a similar long term P/E and margin profile.

ARMK: Contract Timing Delays Will Create FY26 Margin Upside Scenario

Analysts recently trimmed their Aramark price target to $44 from $49, pointing to what they describe as strong underlying business momentum, but also to client driven timing delays on new contract starts that are expected to shift some revenue and margin impact into FY26. Analyst Commentary Bullish Takeaways Bullish analysts see the lower US$44 price target as reflecting updated timing rather than a change in their view of Aramark’s underlying business momentum.

Is Aramark (NYSE:ARMK) Worth US$38.0 Based On Its Intrinsic Value?

Jan 06
Is Aramark (NYSE:ARMK) Worth US$38.0 Based On Its Intrinsic Value?

ARMK: Delayed Contract Ramps Will Drive Stronger Earnings Setup In Fiscal 2026

Analysts have modestly reduced their price target on Aramark to approximately $44 from about $49, citing strong underlying business momentum but near term revenue and earnings pressure from client driven timing delays in new contract starts, which are now expected to shift more meaningfully into FY26. Analyst Commentary Bullish Takeaways Bullish analysts highlight that underlying business momentum remains solid across key operating segments, supporting confidence in the company’s long term growth trajectory despite near term volatility.

ARMK: Delayed Contract Starts Will Support Stronger Earnings Momentum In Fiscal 2026

Analysts have trimmed their price target on Aramark to $44 from $49, reflecting expectations for strong underlying momentum but a near term zig zag in revenue and margins as client driven contract start delays shift more growth into FY26. Analyst Commentary Street research indicates that the recent price target reduction reflects adjustments to the timing of expected growth rather than a reset of the long term thesis.

ARMK: Delayed Contract Starts Will Shift Earnings Momentum Toward Fiscal 2026

Analysts have modestly raised their Aramark price target to approximately $44.60 per share from about $44.43, citing strong underlying business momentum despite near term revenue and earnings pressure from client driven delays in new contract starts, which are now expected to shift growth into FY26. Analyst Commentary Recent Street research highlights a mixed, but generally constructive, view on Aramark, with analysts fine tuning their expectations to reflect both the strength of the core business and the impact of timing related revenue shifts.

Earnings Miss: Aramark Missed EPS By 19% And Analysts Are Revising Their Forecasts

Nov 20
Earnings Miss: Aramark Missed EPS By 19% And Analysts Are Revising Their Forecasts

ARMK: Delayed Contract Starts Will Drive Revenue Expansion Beyond Fiscal 2025

Aramark's analyst price target has been revised downward from $45.10 to $44.43, as analysts factor in strong underlying business momentum while adjusting for delays in revenue and earnings due to client-driven timing in new contract starts. Analyst Commentary Analyst perspectives on Aramark reflect a mix of optimism about core business trends and caution around near-term uncertainty driven by client timing.

What Is Aramark's (NYSE:ARMK) Share Price Doing?

Oct 01
What Is Aramark's (NYSE:ARMK) Share Price Doing?

Sports, Education And Healthcare Wins Will Expand Global Reach

Aramark’s fair value estimate was slightly reduced as a result of a deteriorating net profit margin and an increased future P/E, indicating weaker profitability and pricier valuation. What's in the News Aramark expanded its presence in NCAA collegiate sports by delivering customized hospitality experiences at over 30 football stadiums and secured new partnerships with Arizona State University and the University of Nebraska.

Is Aramark (NYSE:ARMK) Using Too Much Debt?

Jul 07
Is Aramark (NYSE:ARMK) Using Too Much Debt?

Is It Time To Consider Buying Aramark (NYSE:ARMK)?

Jun 16
Is It Time To Consider Buying Aramark (NYSE:ARMK)?

Aramark's (NYSE:ARMK) 25% Jump Shows Its Popularity With Investors

May 08
Aramark's (NYSE:ARMK) 25% Jump Shows Its Popularity With Investors

Aramark Is A 'BUY', But With Some Details (Rating Upgrade)

Apr 28

Aramark: Rating Downgrade To Hold As I See Risk To The Company Meeting FY25 Guidance

Feb 08

Aramark: Robust FY25 Outlook

Nov 22

Aramark: Switching To Sodexo After M&A Talk

Sep 27
User avatar

Calculated Expansions And Efficiency Gains Propel Revenue And Profitability Forward

Aramark's focus on new client acquisition and retention promises enhanced revenue growth and improved profitability margins through strategic growth initiatives.

Aramark: Visible Path To Both Revenue And EBIT Growth

Jun 30

Earnings and Revenue Growth Forecasts

NYSE:ARMK - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202822,3416956891,2949
9/30/202721,0316176231,19416
9/30/202619,8035075151,01716
1/2/202618,786317234726N/A
10/3/202518,506326432921N/A
6/27/202517,875362281767N/A
3/28/202517,624348371831N/A
12/27/202417,545340365796N/A
9/27/202417,401263299727N/A
6/28/202417,184248328741N/A
3/29/202416,861477207623N/A
12/29/202316,577438306717N/A
9/29/202316,083448383766N/A
6/30/202316,273415180566N/A
3/31/202316,348169144530N/A
12/30/202216,292190187591N/A
9/30/202213,68739383694N/A
7/1/202215,487154-132281N/A
4/1/202214,341146-126307N/A
12/31/202113,30033-143269N/A
10/1/202112,096-91249657N/A
7/2/202111,237-275111485N/A
4/2/202110,408-564137490N/A
1/1/202111,320-689-18371N/A
10/2/202012,830-462-242177N/A
6/26/202014,089-227240701N/A
3/27/202015,947112317804N/A
12/27/201916,216344N/A878N/A
9/27/201916,227449N/A984N/A
6/28/201916,190538N/A1,115N/A
3/29/201916,151528N/A1,119N/A
12/28/201816,090526N/A1,160N/A
9/28/201815,790568N/A1,052N/A
6/29/201815,530506N/A750N/A
3/30/201815,152498N/A647N/A
12/29/201714,834541N/A768N/A
9/29/201714,604374N/A1,053N/A
6/30/201714,494344N/A906N/A
3/31/201714,488324N/A1,044N/A
12/30/201614,441320N/A1,010N/A
9/30/201614,416288N/A867N/A
7/1/201614,418261N/A936N/A
4/1/201614,317250N/A856N/A
1/1/201614,337244N/A758N/A
10/2/201514,329236N/A802N/A
7/3/201514,731223N/A573N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ARMK's forecast earnings growth (17.8% per year) is above the savings rate (3.5%).

Earnings vs Market: ARMK's earnings (17.8% per year) are forecast to grow faster than the US market (16.1% per year).

High Growth Earnings: ARMK's earnings are forecast to grow, but not significantly.

Revenue vs Market: ARMK's revenue (5.9% per year) is forecast to grow slower than the US market (11.3% per year).

High Growth Revenue: ARMK's revenue (5.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ARMK's Return on Equity is forecast to be low in 3 years time (17.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/06 03:24
End of Day Share Price 2026/05/06 00:00
Earnings2026/01/02
Annual Earnings2025/10/03

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Aramark is covered by 23 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andrew WittmannBaird
Manav PatnaikBarclays
Stuart GordonBerenberg